Home » Amgen, Array BioPharma Enter Development Agreement
Amgen, Array BioPharma Enter Development Agreement
Biotech drug developer Amgen Inc. has entered an agreement with Array BioPharma Inc.
to develop a potential treatment for type 2 diabetes, the companies said.
TheStreet
TheStreet
Upcoming Events
-
07May
-
14May
-
30May